Letko, Brosseau & Associates’s Myovant Sciences Ltd. MYOV Stock Holding History

Letko, Brosseau & Associates’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-63,204	Closed	-$1.14M	–	105
2022 Q3	$1.14M	Hold	63,204	–	–	0.02%	82
2022 Q2	$786K	Hold	63,204	–	–	0.01%	85
2022 Q1	$842K	Hold	63,204	–	–	0.01%	87
2021 Q4	$984K	Hold	63,204	–	–	0.01%	90
2021 Q3	$1.42M	Hold	63,204	–	–	0.02%	87
2021 Q2	$1.44M	Hold	63,204	–	–	0.02%	86
2021 Q1	$1.3M	Hold	63,204	–	–	0.02%	85
2020 Q4	$1.75M	Buy	63,204 +13,204	+26%	+$257K	0.02%	86
2020 Q3	$703K	Sell	50,000 -1,500	-3%	-$27.9K	0.01%	87
2020 Q2	$1.06M	Buy	+51,500	New	+$701K	0.02%	85

Other funds holding MYOV

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Letko, Brosseau & Associates's MYOV Position: Q4 2022 in Review

Letko, Brosseau & Associates sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 63,204 shares — an estimated $1.14M sold.

Letko, Brosseau & Associates first reported a position in MYOV in Q2 2020 and held it in 10 quarters. The position peaked at $1.75M in Q4 2020. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

Letko, Brosseau & Associates reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
Letko, Brosseau & Associates sold 63,204 Myovant Sciences Ltd. shares in Q4 2022, an estimated $1.14M.
Letko, Brosseau & Associates first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 10 quarters.
Letko, Brosseau & Associates's Myovant Sciences Ltd. position peaked at $1.75M in Q4 2020.
118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Letko, Brosseau & Associates's 13F filing for Q4 2022, filed 10 Feb 2023.